Welcome to LookChem.com Sign In|Join Free

CAS

  • or

776296-12-9

Post Buying Request

776296-12-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

776296-12-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 776296-12-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,6,2,9 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 776296-12:
(8*7)+(7*7)+(6*6)+(5*2)+(4*9)+(3*6)+(2*1)+(1*2)=209
209 % 10 = 9
So 776296-12-9 is a valid CAS Registry Number.

776296-12-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H54919)  5-Bromo-3-methoxyquinoline, 96%   

  • 776296-12-9

  • 250mg

  • 568.0CNY

  • Detail
  • Alfa Aesar

  • (H54919)  5-Bromo-3-methoxyquinoline, 96%   

  • 776296-12-9

  • 1g

  • 1705.0CNY

  • Detail
  • Alfa Aesar

  • (H54919)  5-Bromo-3-methoxyquinoline, 96%   

  • 776296-12-9

  • 5g

  • 6821.0CNY

  • Detail

776296-12-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-bromo-3-methoxyquinoline

1.2 Other means of identification

Product number -
Other names 5-bromo-3-methoxy-quinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:776296-12-9 SDS

776296-12-9Relevant articles and documents

Synthetic method of 3-methoxyquinoline-5-amine

-

Paragraph 0030-0035; 0042-0047; 0054-0059, (2021/11/19)

The embodiment of the invention discloses a synthesis method of 3-methoxyquinoline-5-amine, relates to the technical field of synthesis of heterocyclic compounds, and aims to effectively synthesize the 3-methoxyquinoline-5-amine. The synthesis method comprises the following steps: taking 5-bromo-3-methoxyquinoline and benzophenone imine as raw materials, carrying out a coupling reaction at 45-120 DEG C to obtain an intermediate compound, and treating the intermediate compound at 25-30 DEG C by using hydroxylamine hydrochloride under an alkaline condition to obtain 3-methoxyquinoline-5 amine. The synthesis method provided by the embodiment of the invention is used for synthesizing the quinoline compound.

Mapping the reactivity of the quinoline ring-system – Synthesis of the tetracyclic ring-system of isocryptolepine and regioisomers

H?heim, Katja S.,Urdal Helgeland, Ida T.,Lindb?ck, Emil,Sydnes, Magne O.

, p. 2949 - 2957 (2019/04/25)

Bromoquinolines (2-bromoquinoline – 8-bromoquinoline and 5-bromo-3-methoxyquinoline) and 2-aminophenylboronic acid hydrochloride were subjected to Suzuki-Miyaura cross-coupling conditions resulting in formation of the desired biaryl systems in good yields. The resulting biaryls were then subjected to palladium catalyzed C–H activation/C–N bond formation utilizing PdCl2(dppf). The reactions revealed large differences in reactivity depending on the attachment point for the 2-aminophenyl group on the quinoline. The variation in the reactivity was rationalized based on the electron distribution around the quinoline ring-system.

Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity

Surivet, Jean-Philippe,Zumbrunn, Cornelia,Rueedi, Georg,Hubschwerlen, Christian,Bur, Daniel,Bruyère, Thierry,Locher, Hans,Ritz, Daniel,Keck, Wolfgang,Seiler, Peter,Kohl, Christopher,Gauvin, Jean-Christophe,Mirre, Azely,Kaegi, Verena,Dos Santos, Marina,Gaertner, Mika,Delers, Jonathan,Enderlin-Paput, Michel,Boehme, Maria

supporting information, p. 7396 - 7415 (2013/10/21)

There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the potential

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 776296-12-9